Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database

Fig. 3

Safety signals (ROR) of combination therapy (pembrolizumab + pemetrexed + platinum) and chemotherapy alone (pemetrexed + platinum) were compared at the PT level. The confidence interval to the right of the null effect line (ROR = 1) indicates a higher risk of adverse events in the combination therapy group. Abbreviations: PT, preferred term; PPP, pemetrexed and platinum with pembrolizumab; PP, pemetrexed and platinum; ROR, reporting odds ratio; CI, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us